본문 바로가기
KERD
논문KCI 등재

Exposure to Secondhand Smoke and a Tobacco-Specific Carcinogen in Non-Smokers

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류가정의학

초록

Background: The International Agency for Research on Cancer classifies 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) as a known carcinogen. This study aimed to investigate the association between exposure to secondhand smoke (SHS) and NNAL concentrations in non-smokers.Methods: This was a cross-sectional study based on data from the 2016 to 2018 Korea National Health and Nutri-tion Examination Survey. Urine NNAL concentrations were categorized into tertiles of 3,615 study participants who were non-smokers. All sampling and weight variables were stratified, and analyses to account for the complex sam-pling design were conducted.Results: The overall, male, and female percentages of SHS exposure among non-smokers were 22.4%, 29.2%, and 20.4%, respectively. The geometric means of urine NNAL concentrations were 1.896±0.098 pg/mL and 1.094±0.028 pg/mL in the SHS exposure and non-exposure groups, respectively. After adjusting for confounding variables, in the total group, the geometric mean of urine NNAL concentrations was significantly higher in the SHS exposure group than in the SHS non-exposure group (adjusted P-value <0.001). Compared with the non-exposure group, the adjusted odds ratios (95% confidence intervals) for the highest NNAL tertile group of overall SHS exposure in the total, men, and women groups were 2.44 (1.95–3.05), 1.65 (1.08–2.53), and 2.73 (2.11–3.52), respectively, after full adjustment.Conclusion: The urine NNAL concentration in the SHS exposure group was significantly higher than that in the non-exposure group. Exposure to SHS was associated with a higher risk of elevated urine NNAL concentrations in non-smokers.

Abstract

Background: The International Agency for Research on Cancer classifies 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) as a known carcinogen. This study aimed to investigate the association between exposure to secondhand smoke (SHS) and NNAL concentrations in non-smokers.Methods: This was a cross-sectional study based on data from the 2016 to 2018 Korea National Health and Nutri-tion Examination Survey. Urine NNAL concentrations were categorized into tertiles of 3,615 study participants who were non-smokers. All sampling and weight variables were stratified, and analyses to account for the complex sam-pling design were conducted.Results: The overall, male, and female percentages of SHS exposure among non-smokers were 22.4%, 29.2%, and 20.4%, respectively. The geometric means of urine NNAL concentrations were 1.896±0.098 pg/mL and 1.094±0.028 pg/mL in the SHS exposure and non-exposure groups, respectively. After adjusting for confounding variables, in the total group, the geometric mean of urine NNAL concentrations was significantly higher in the SHS exposure group than in the SHS non-exposure group (adjusted P-value <0.001). Compared with the non-exposure group, the adjusted odds ratios (95% confidence intervals) for the highest NNAL tertile group of overall SHS exposure in the total, men, and women groups were 2.44 (1.95–3.05), 1.65 (1.08–2.53), and 2.73 (2.11–3.52), respectively, after full adjustment.Conclusion: The urine NNAL concentration in the SHS exposure group was significantly higher than that in the non-exposure group. Exposure to SHS was associated with a higher risk of elevated urine NNAL concentrations in non-smokers.

참고문헌 (35)

  1. 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
  2. Korea Health Statistics 2019: Korea National Health and Nutrition Examination Survey 2020, "Korea Disease Control and Prevention Agency", Ministry of Health and Welfare, ~ (2020)
  3. 박지영, "Epidemiology of Lung Cancer in Korea: Recent Trends", Tuberculosis and Respiratory Diseases, 79(2), pp.58~69 (2016), 대한결핵및호흡기학회
  4. Planchard D, "Lung cancer in never-smokers", Eur Respir J, 45, pp.1214~1217 (2015)
  5. 신애선, "Lung Cancer Epidemiology in Korea", Cancer Research and Treatment, 49(3), pp.616~626 (2017), 대한암학회
  6. World Health Organization, "Tobacco Free Initiative. Protection from exposure to second-hand tobacco smoke: policy recommendations", World Health Organization, ~ (2007)
  7. GBD 2016 Risk Factors Collaborators, "Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016 : a systematic analysis for the Global Burden of Disease Study 2016", Lancet, 390, pp.1345~1422 (2017)
  8. Lee CC, "Association of secondhand smoke exposure with pediatric invasive bacterial disease and bacterial carriage : a systematic review and meta-analysis", PLoS Med, 7, pp.e1000374~ (2010)
  9. Kim CH, "Exposure to secondhand tobacco smoke and lung cancer by histological type : a pooled analysis of the International Lung Cancer Consortium(ILCCO)", Int J Cancer, 135, pp.1918~1930 (2014)
  10. Kim KH, "Secondhand smoke exposure and osteoporosis in never-smoking postmenopausal women : the Fourth Korea National Health and Nutrition Examination Survey", Osteoporos Int, 24, pp.523~532 (2013)
  11. Stayner L, "Lung cancer risk and workplace exposure to environmental tobacco smoke", Am J Public Health, 97, pp.545~551 (2007)
  12. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, "Tobacco smoke and involuntary smoking", IARC Monogr Eval Carcinog Risks Hum, 83, pp.1~1438 (2004)
  13. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, "Personal habits and indoor combustions. Volume 100 E : a review of human carcinogens", IARC Monogr Eval Carcinog Risks Hum, 100(Pt E), pp.1~538 (2012)
  14. Hecht SS, "A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke", N Engl J Med, 329, pp.1543~1546 (1993)
  15. Carlson ES, "Analysis and identification of 2’-deoxyadenosine-derived adducts in lung and liver DNA of F-344 rats treated with the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol", Chem Res Toxicol, 31, pp.358~370 (2018)
  16. Hecht SS, "Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines", Chem Res Toxicol, 11, pp.559~603 (1998)
  17. Kovi RC, "Metastasis to the F344 rat pancreas from lung cancer induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, constituents of tobacco products", Toxicol Pathol, 46, pp.184~192 (2018)
  18. Kim Y, "The Korea National Health and Nutrition Examination Survey(KNHANES) : current status and challenges", Epidemiol Health, 36, pp.e2014002~ (2014)
  19. SRNT Subcommittee on Biochemical Verification, "Biochemical verification of tobacco use and cessation", Nicotine Tob Res, 4, pp.149~159 (2002)
  20. Chang Y, "Long-term trends in smoking prevalence and its socioeconomic inequalities in Korea, 1992-2016", Int J Equity Health, 18, pp.148~ (2019)
  21. Park DK, "Trends in secondhand smoke exposure among nonsmokers in the Korean population : the 2008-2011 Korean National Health and Nutrition Examination Survey", Korean J Fam Pract, 6, pp.568~576 (2016)
  22. Park YS, "Association between secondhand smoke exposure and hypertension in never smokers : a cross-sectional survey using data from Korean National Health and Nutritional Examination Survey V, 2010-2012", BMJ Open, 8, pp.e021217~ (2018)
  23. Kim AS, "Exposure to secondhand smoke and risk of cancer in never smokers : a meta-analysis of epidemiologic studies", Int J Environ Res Public Health, 15, pp.1981~ (2018)
  24. Stratton K, "Clearing the smoke: assessing the science base for tobacco harm reduction" (2001), National Academies Press
  25. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General, "Office on Smoking and Health", Centers for Disease Control and Prevention, ~ (2006)
  26. Hoffmann D, "The less harmful cigarette: a controversial issue: a tribute to Ernst L. Wynder", Chem Res Toxicol, 14, pp.767~790 (2001)
  27. Hoffmann D, "Chemical carcinogenesis and mutagenesis I", pp.63~102 (1990), Springer
  28. Bernert JT, "Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U. S. population from secondhand smoke exposure", Cancer Epidemiol Biomarkers Prev, 19, pp.2969~2977 (2010)
  29. Miller JA, "Research in chemical carcinogenesis with Elizabeth Miller : a trail of discovery with our associates", Drug Metab Rev, 26, pp.1~36 (1994)
  30. Hecht SS, "Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines", Acc Chem Res, 49, pp.106~114 (2016)
  31. Akopyan G, "Understanding tobacco smoke carcinogen NNK and lung tumorigenesis", Int J Oncol, 29, pp.745~752 (2006)
  32. Park E, "Attitudes of Korean smokers towards smoke-free public places : findings from the longitudinal ITC Korea Survey, 2005-2010", BMJ Open, 9, pp.e025298~ (2019)
  33. Park S, "Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea", BMC Cancer, 14, pp.406~ (2014)
  34. Carreras G, "Burden of disease attributable to second-hand smoke exposure : a systematic review", Prev Med, 129, pp.105833~ (2019)
  35. Kang SY, "Trends in the socioeconomic inequalities related to second-hand smoke exposure as verified by urine cotinine levels among nonsmoking adults : Korea National Health and Nutrition Examination Survey 2008-2018", Nicotine Tob Res, 23, pp.1518~1526 (2021)

관련 논문AI추천

이 간행물의 다른 논문 (9건)